Nasdaq-Listed Company Announces Major Solana (SOL) Purchase – “Like MicroStrategy…”

Nasdaq-listed Solana Company (formerly Helius Medical Technologies) announced that it has accumulated more than 2.2 million SOL as part of its digital asset treasury strategy. The price of SOL is currently at $235, bringing the total value of the company's SOL assets and cash reserves to approximately $530 million. This amount exceeds the gross proceeds from the company's private sale in September. Related News: Will Pro-Crypto Decisions in the US Be Reversed After Trump? Bitwise CEO Responds Cosmo Jiang, general partner at Pantera Capital and board observer at Solana Company, commented on the matter: “We are following in the footsteps of Michael Saylor at Strategy and Tom Lee at Bitmine. As HSDT Solana Company, we are efficiently accumulating SOL to maximize shareholder value.” Solana Company CEO Joseph Chee stated that institutional interest has been much stronger than expected, particularly following recent digital asset conferences in Asia. This move places Solana Company among the publicly traded companies that consider Solana an asset on their balance sheet. *This is not investment advice. Continue Reading: Nasdaq-Listed Company Announces Major Solana (SOL) Purchase – “Like MicroStrategy…”